• Inovio: A Rising Star in the World of Vaccines

    September 19, 2011 | In as few as five years, all of the major shortcomings of conventional vaccines will start to vanish as the first DNA-based vaccines hit the market. The vaccines will be remarkably safe and tolerable, easily modified, and cheap to produce in a manufacturing process akin to brewing beer. They’ll also have a long shelf life, maintaining their fidelity even in steamy tropical climates. The development process itself will better integrate scientific inquiry with trial design, so that subsequent vaccines improve with the regularity of an iPhone upgrade. 

     

    Sep 18, 2011

  • Facebook and Pharma – an Uneasy Alliance

    September 19, 2011 | On August 15, 2011, Facebook implemented a change in policy that redefines the ground rules for the pharmaceutical industry’s use of this popular social medium.  As of that date, pharma companies no longer have the privilege of disabling comment walls on their company-sponsored Facebook pages.  The inability of consumers to post or view comments had been a special accommodation from Facebook to the pharmaceutical industry, but no more.    

    Sep 18, 2011

  • Less than 1% of Cancer Patients Enrolled in Trials, Study Says

     

    August 29, 2011 | Less than 1% of cancer patients participate in a clinical trial, according to a study published in the September issue of the Annals of Surgery. 

     

    Aug 28, 2011

  • Trials at the Point-of-Care

    eCliniqua | A new type of clinical trial now undergoing testing at the Veterans Affairs (VA) Boston Healthcare System will likely be of interest to emerging accountable care organizations (ACOs) as well as the drug companies that court them. The new approach, most useful in comparative effectiveness research, overcomes the chief disadvantages of the two flanking options: an observational study involving non-experimental treatment decision making or a full-scale, randomized and placebo-controlled trial. 

     

    Aug 15, 2011

  • ClearTrials Releases Study Budgeting Survey Results

    By eCliniqua Staff August 4, 2011 | ClearTrial, maker of clinical trial operations software for planning and budgeting trials, released results of a survey earlier this week assessing how life sciences professionals forecast and budget for clinical trials. Almost half of the

    Aug 4, 2011

  • Cetero Responds to FDA Letter

    eCliniqua | On Wednesday, one day after the FDA issued a letter accusing CRO Cetero of "significant violations" at a Cetero facility in Houston, the company responded in a letter on its website.  

     

    Jul 29, 2011

  • Trial Finder Launched for Parkinson's Trials

    July 18, 2011 | The Michael J. Fox Foundation for Parkinson's Research has launched a Web-based solution to connect patients with Parkinson's Disease clinical trials. The beta version of the Fox Trial Finder (www.foxtrialfinder.org) compares volunteer information such as location and medical history with trial eligibility requirements to find the best potential matches at study sites nearby. The service matches both people with Parkinson's and control volunteers with the trials that need them.   

     

    Jul 17, 2011

  • DIA 2011—Compliance, Collaboration and the Cloud

    By Ann Neuer  July 13, 2011 | CHICAGO—This year’s annual DIA meeting featured hundreds of exhibitors and session topics ranging from patient recruitment to cloud computing to improving regulatory reporting. There were several overriding themes including the continuing march towards

    Jul 13, 2011

  • Using Interim Analyses to Improve Efficiency in Drug Development

    Jun 3 | Guest Commentary | Interim analyses offer companies the opportunity to stop studies early when it appears the primary objective will not be achieved or halt trials when there is clear evidence that the primary objective has already been met. This not only lowers costs but also speeds up the time to develop the compound, which obviously benefits both the company and patients.    

     

    Jun 2, 2011

  • Euphoria over EHR/EDC Interoperability May be Misplaced

    May 16 | eCliniqua | Despite noble efforts by the Clinical Data Interchange Standards Consortium (CDISC) and others to write a rulebook for the exchange of patient-level clinical information between electronic health records (EHRs) and electronic data capture (EDC), interoperability between the two systems is largely a pipe dream.

    May 13, 2011

  • MD Anderson Chooses Velos eResearch

    May 13 | News Brief | MD Anderson has signed an agreement for an enterprise-wide installation of Velos eResearch for use in clinical trials. The installation is underway now and should be in use by 2012.

    May 13, 2011

  • eHealth University Unveiled

    May 11 | News Brief | This week, National eHealth Collaborative (NeHC) unveiled NeHC University, a revamping and substantial expansion of its NHIN University program.

    May 11, 2011

  • ClearTrial Named Cool Vendor

    May 4 | News Brief | ClearTrial is in the list of "Cool Vendors" in the "Cool Vendors in Life Sciences, 2011" report by Gartner. 

    May 3, 2011

  • Inaugural Study of Lung Cancer Medical Institute Enrolls Patients

    May 4 | News Brief | Biodesix has announced the enrollment of initial subjects into CASTLE, the inaugural study of the Addario Lung Cancer Medical Institute. The study collects biospecimens and data from lung cancer patients in order to facilitate and accelerate the development and delivery of diagnostic tests.

    May 3, 2011

  • RxTrials, Integra Enter Partnership

    Apr 28 | San Antonio Business Journal | Integra Clinical Research and RxTrials have entered a partnership that will allow Integra to become a partner research site with RxTrials.

    Apr 28, 2011

  • Lilly, Medtronic Enter Parkinson's Collaboration

    Apr 26 | News Brief | Eli Lilly and Company and Medtronic have entered into a collaboration to research and develop a new approach to treating Parkinson’s disease that involves delivering a potential new  medicine to the brain using an implantable drug delivery system.

    Apr 28, 2011

  • Perceptive Relases Adaptive Trial Survey

    Apr 28 | Outsourcing Pharma | Perceptive Informatics has released the results of a recent global survey thats shows a growing interest in adaptive trial design. During a recent webinar presented by Perceptive and Tessella, more than 300 industry professionals answered questions about implementing adaptive trials.

    Apr 28, 2011

  • Oracle Software Supporting Moffitt’s Personalized Medicine Ambitions

    Apr 28 | eCliniqua | Moffitt Cancer Center recently announced that it selected Oracle Health Sciences solutions as the foundation for its next-generation health and research informatics platform. The groundbreaking partnership will support efforts by Moffitt’s longitudinal research initiative Total Cancer Care (TCC) to supply doctors of the future with a bedside decision-making tool for better matching patients to trials and treatments.

    Apr 28, 2011

  • Little Israel—Big in Clinical Trials

    Apr 18 | eCliniqua | Israel, a small country of seven million, often described as the size of New Jersey, has emerged as a clinical trials powerhouse. With its highly skilled workforce, widespread adherence to good clinical practice (GCP), and strong patient enrollment rates with relatively few lost to follow-up, global life sciences companies view Israel as a key clinical trials destination.

    Apr 6, 2011

  • Batter Up: A Stratified Approach to Rheumatoid Arthritis

    Apr 7 | eCliniqua | Mark Curran, senior director of immunology biomarkers at Centocor R&D, joined the organization five years ago and was tasked with a broad mission: to supply biomarkers to various compound-development teams and discovery R&D at Centocor R&D. Curran spoke with Bio•IT World managing editor, Allison Proffitt, about his vision for stratified medicine at Centocor R&D and the new Biomarkers of Anti-TNF Treatment Efficacy in Rheumatoid Arthritis-Unresponsive Populations (BATTER-UP) consortium announced in November.

    Apr 7, 2011